Korean J Intern Med.  2014 Nov;29(6):830-833. 10.3904/kjim.2014.29.6.830.

Transformation into large-cell neuroendocrine carcinoma associated with acquired resistance to erlotinib in nonsmall cell lung cancer

Affiliations
  • 1Division of Hematology and Oncology, Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. insookwoo@catholic.ac.kr
  • 2Division of Pulmonology, Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • 3Department of Hospital Pathology, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • 4Department of Radiology, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Abstract

No abstract available.

Keyword

Erlotinib; Acquired resistance; Neuroendocrine

MeSH Terms

Adenocarcinoma/chemistry/*drug therapy/secondary
Adult
Antineoplastic Agents/*therapeutic use
Biopsy
Carcinoma, Large Cell/chemistry/*pathology
Carcinoma, Neuroendocrine/chemistry/*pathology
Carcinoma, Non-Small-Cell Lung/chemistry/*drug therapy/secondary
*Drug Resistance, Neoplasm
Humans
Lung Neoplasms/chemistry/*drug therapy/pathology
Magnetic Resonance Imaging
Male
Protein Kinase Inhibitors/*therapeutic use
Quinazolines/*therapeutic use
Tomography, X-Ray Computed
Treatment Outcome
Tumor Markers, Biological/analysis
Antineoplastic Agents
Protein Kinase Inhibitors
Quinazolines
Tumor Markers, Biological
Full Text Links
  • KJIM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr